While robust regulatory mechanisms are expected to control the production of splice variants that confer distinct functions, a low level of stochasticity may be tolerated. To investigate stringency of regulation, we followed changes in the splicing of 192 alternative cassette exons after growth of cancer-derived HCT116 cells and embryonic colonocytes. In both cell lines approximately 15% of alternative splicing events changed by more than 10 percentage points over a 42-day period. We then carried out a cycle of transient depletions targeting RNPS1, a splicing regulator implicated in genomic stability. For alternative splicing units not regulated by RNPS1, the level of splicing changes was similar to the stochastic value obtained after normal growth. However, the frequency of perdurable changes was at least twice that value for splicing events regulated by RNPS1. A swap allele assay performed on four RNPS1-responsive units that underwent splicing changes indicated the presence of mutations mediating this effect. Specifically, a T to C mutation in a RNPS1-responsive exon of ADARB1 confered exon skipping. Our results suggest that fluctuations in the level of a splicing regulator preferentially impact the integrity of genes encoding transcripts that are regulated by this splicing factor to produce perdurable changes in alternative splicing. We discuss the potential implication of this process in human evolution.
INTRODUCTION
Alternative splicing of pre-messenger RNAs plays a central role in mammals by allowing protein diversification and complex biological function 1, 2 . In humans, nearly all multi-exon genes are alternatively spliced, with the brain being the most diligent user of this process [3] [4] [5] . Alternative splicing is often regulated in a tissue-, cell-and stress-specific manner 1 . Control of alternative splicing based on daily changes in body temperature also occurs 6 . Splicing control requires the interplay of RNA binding proteins (RBPs) that interact with the pre-mRNA to modulate the recognition of splicing signals, thereby altering steps of spliceosome assembly that define the introns to be removed 7 . SR and hnRNP proteins are well-known splicing regulators, but dozens transcription, promote mutations and hyper-recombination [13] [14] [15] . mRNA processing factors play a widespread role in preventing R-loop-mediated DNA damage in mammalian cells 16 .
Specifically, splicing factors such as SR and SR-like proteins are important to maintain genomic stability [17] [18] [19] . Inactivation of SRSF1 provokes the accumulation of R-loops, and overexpression of the SR-related protein RNPS1 can rescue defects caused by the loss of SRSF1 18 . Based on these observations, we hypothesized that genomic instability triggered by the depletion of a specific RBP could produce mutations with a perdurable effect on splicing. Our study provides a first test of this model; we show that transient drops in RNPS1 can lead to perdurable changes preferentially affecting the splicing of alternative exons that are normally regulated by RNPS1.
These results raise the possibility that physiological, environmental or stress-induced changes in the abundance of a specific RBPs may permanently impact the alternative splicing of events that are normally regulated by these RBPs.
RESULTS

Changes in alternative splicing during cell growth in culture
To test the hypothesis that the depletion of a RBP can promote permanent change in splicing we focused on the splicing factor RNPS1 because its overexpression rescues the genomic instability induced by depleting SRSF1 18 . A doxycycline inducible plasmid that expresses a shRNA targeting RNPS1 was transfected into HCT116 and three individual sublines were isolated. The expression of RNPS1 after shRNA induction (t7si) was measured, as well as 7 days after removing induction (t7si+7) (Supplementary Figure 1A) . Quantitative RT-PCR indicates that expression of RNPS1 transcripts dropped by more than 50% in all three sublines, and that expression was back to normal levels 7 days after stopping shRNA induction. Although we could not find a reliable source of commercial anti-RNPS1 antibody to confirm these results, this level of depletion of RNPS1 transcripts in the t7si samples was sufficient to change the alternative splicing of two known targets of RNPS1, Bcl-x and SLIT2 20 (Supplementary Figure 1B) . Table IA) . We also recorded the appearance and disappearance of unassigned amplicons relative to t0, with the caveat that the identity of these products was not validated by sequencing. When all types of changes were considered (i.e. ∆PSI larger than 10 percentage points on annotated events, and appearance/disappearance of unassigned amplicons),
28.5% ± 8.0% of the ASEs displayed a change at t42, with 102 of the 192 ASEs experiencing a change when all three sublines are considered (Supplementary Table IB) .
The average rate of change at shorter time points (7 and 14 days) was equivalent. Using a subset of 96 ASEs, the average frequency of ∆PSI larger than 10 percentage points was 18.4% ± 6.3%, 17.0% ± 9.5% and 10.1% ± 5.7% for t7, t14 and t42, respectively (Supplementary Table IIA RNPS1 is also an auxiliary component of the exon junction complex (EJC) and participates in non-sense mediate RNA decay (NMD). We asked if the profile of our set of RNPS1-responsive ASEs was controlled by NMD. Two sublines were treated with the translation inhibitor emetine, which blocks translation and hence NMD 23 . The production of amplicons for three ASEs was affected by emetine, but only NFAT5-1 produced a PSI shift in the same direction as ∆RNPS1, and in only one of the two sublines tested (Supplementary Table IVB ),
indicating that NMD is not appreciably modulating the profile of splice variants in our set of selected events.
We then performed successive rounds of induction of shRNPS1 in the three HCT116
sublines (three 7-day inductions each followed by a 7-day recovery period). Considering ∆PSI larger than 10 percentage points, an average of 37.6% ± 2.1% of the RNPS1 responsive Given that cells had a full week to recover after the last depletion of RNPS1, it is unlikely that shifts were caused by a delayed recovery in the splicing profiles of RNPS1 R units. If it had been that case, a greater level of systematic effect would have been expected. Morever, 7 of the 20 perdurable changes in subline 1 occurred in a polarity different from the impact of a direct depletion of RNPS1 (white boxes in Figure 1 ).
Mutations in ASEs cause perdurable splicing changes
The increased frequency of change in RNPS1-responsive ASEs could be due to cis-acting or trans-acting mechanisms. A trans-acting mechanism would occur if an alteration in the expression or activity of a regulatory RBP (RNPS1 or another splicing regulator). In contrast, a cis-acting effect could be due to a mutation in the alternative splicing unit itself that may have been triggerred by the transient depletion of RNPS1. Consistent with the view that the depletion of RNPS1 can trigger R-loop-mediated genomic instability, the RNPS1 depletion stimulated the phosphorylation of H2AX, a known marker of genomic instability (Supplementary Figure 4) .
Co-expression of RNase H1, which reduces the accumulation of R-loops, prevented this stimulation (Supplementary Figure 4) .
To distinguish between trans-and cis-acting mechanisms, we conducted a swap-allele assay. The assay involves amplifying the genomic copy of an ASE in t0 cells and in cells that have experienced the transient RNPS1 depletion protocol (t42PER). Units were cloned in minigenes that were then transfected in t0 and t42PER cells (Figure 2A) . If the change in splicing is due to a mutation, the t42PER unit should be spliced the same way in t0 and t42PER cells. If the effect is trans-acting, the t42PER unit should be spliced differently in t0 and t42PER cells, and the t0 unit should be spliced like a t42PER unit in t42RNPS1 cells. Units of ADARB1-1 were amplified, cloned and transfected using the above protocol. The t0 unit of ADARB1-1 was spliced similarly in t0 and t42PER cells (boxes 1 and 3 in Figure 2B , left panel). The splicing profile of the t42PER unit of ADARB1-1 transfected in t0 and t42PER cells was also consistent with a cis-acting mechanism (boxes 2 and 4; Figure 2B , left panel). t0 and t42PER units of PPIL2, ABCD4 and IFNLR1 transfected in t0 cells produced splicing profiles also consistent with the existence of mutations in their t42PER units (boxes 1 and 2 in Figure 2B , right panel).
The cloned t0 and t42PER genomic units of ADARB1-1 were sequenced to reveal several differences distributed along the ASE ( Figure 2C ). Noting a T to C conversion in the alternative exon of the t42PER ADARB1-1 unit near the 3' splice site, we produced a version corrected for a T at this position. This modification restored the t0 splicing profile (Figure 2D ), indicating that the T to C mutation in the t42PER ADARB1-1 unit strongly contributed to the perdurable splicing change. caused by cis-acting events. We further identified a point mutation in the evolved ADARB1 allele that, when converted to its original nucleotide, restored the original splicing profile. Overall, our results suggest that mutations occurring in transiently RNPS1-depleted cells can lead to perdurable splicing changes that will preferentially affect splicing units normally regulated by RNPS1.
DISCUSSION
Our finding has wide-ranging implications, as it implies that stable changes in alternative splicing can be accelerated by variations in the levels of specific RBPs. These changes may occur in somatic tissues during the lifetime of an organism and may contribute to cell adaptation or disease. This process may also be relevant to our understanding of how alternative splicing may have shaped the evolution of mammals. While the evolution of alternative splicing across different evolutionary lineages remains speculative 24 , it is indisputable that genomic changes that impact alternative splicing profiles in complex organs such as the human brain need to occur first in germ cells. Interestingly, gene expression in the brain is often reproduced in testis 25 . Thus, transcription-coupled mutagenesis in testis could potentially lead to alternative splicing changes in the brain, and such changes may have sparked, and may still mold, brain evolution. Notably, Rbm5, Sam68, T-STAR, Celf-1 and Ptbp2 play roles in alternative splicing during mammalian spermatogenesis [26] [27] [28] [29] . Ptbp2 controls over 25% of alternative splicing events during mouse spermatogenesis with a peak of expression that is associated with splicing repression of transcripts encoding splicing regulators such as SRSF1, SRSF2, RNPS1, THOC1, as well as RNASEH2A 30 . Thus, variations in the levels of Ptbp2 could in principle impact the expression of several proteins that contribute to genome stability. Another example is the SR protein RSRC1
that affects intellect and behavior through alternative splicing, and it is expressed both in neurons and testis 25, 31 . Interestingly, small changes in body temperature drive rhythmic SR protein phosphorylation to control alternative splicing 6 . Since testis are subjected to diurnal variation in temperature 32 , this may alter the activity of splicing regulators with a potential effect on genomic integrity. The high rate of transcription during mammalian germ cell differentiation also creates a high demand for splicing factors 33 and may be conducive to R-loop formation 34 . Small and transient drops in the expression of specific RBPs may therefore offer a potential mechanism that drives the rapid evolution of splicing units. If this process occurs in brain-relevant alternatively spliced regions that are intrinsically unstable (like coding VNTR regions 35 ), the rate of evolution of such units may even be faster. Overall, this process may help explain the rapid evolutionary increase in complexity of the human brain, as well as provide a mechanism that continues to produce new configurations at a rapid pace.
MATERIALS AND METHODS
Minigenes
For the shRNPS1/pTER+ plasmid, oligonucleotide pairs were hybridized and inserted in plasmid . Selection was applied 24 hours post-transfection. For the shRNPS1 line we used blasticidin (18 µg/ml; Wisent) and zeocin (400 µg/ml; Invitrogen). For the RNAse H1 line (which was created from a subclone of the HCT116 shRNPS1 line), we used G418 (3 mg/ml; Wisent), blasticidin (9 µg/ml) and zeocin (200 µg/ml). Individual colonies of surviving cells were recovered and resuspended to generate subclones. After selection, drug treatment was maintained at 9 µg/ml blasticidin, 200 µg/ml zeocin (and 1.5 mg/ml G418 for the RNAse H1 line).
For wave of depletions with shRNPS1, t0 was defined as the beginning of the shRNA induction with doxycycline. After 7 days of induction, doxycycline was withdrawn for 7 days.
This cycle was repeated two more times for a total of 42 days (t42). To verify the impact of NMD inactivation, 3 µM emetine (Sigma-Aldrich) was added to the culture medium. For the calculation of the population doubling, we used the following formula:
where No is the quantity of cells initially seeded in the well and Nf is the quantity of cells present in the well at the time of measurement and calculated using a hemacymeter.
RNA extraction and RT-PCR analysis
Cells were washed with PBS and RNA was extracted using TRIzol (Invitrogen). The RNA pellets were washed twice with 900 µl of cold 70% ethanol and resuspended in 20 µl of Nanopure water (Qiagen). The total RNA extracts were subsequently treated with 1U of DNase I (Fermentas) for 30 minutes at 37˚C. DNase I was inactivated by adding EDTA and incubating at 65˚C for 10 minutes.
Reverse transcription was performed with random hexamers for the endogenous mRNAs 
